stockportfolio.pro
Inspire Medical Systems, Inc. P/E Ratio 2016–2025
Inspire Medical Systems, Inc. (INSP) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -17.4%/yr over 9 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 18.86 | -82.2% |
| FY 2024 | 105.93 | — |
| FY 2023 | — | — |
| FY 2022 | — | — |
| FY 2021 | — | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
| FY 2018 | — | — |
| FY 2017 | — | — |
| FY 2016 | — | — |
Source: Inspire Medical Systems, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Inspire Medical Systems, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeInspire Medical Systems, Inc. — frequently asked questions
What is Inspire Medical Systems, Inc.'s price-to-earnings ratio?
Inspire Medical Systems, Inc. (INSP) reported price-to-earnings ratio of 18.86 for fiscal year 2025, per its SEC filings.
How has Inspire Medical Systems, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2016 and 2025, INSP's price-to-earnings ratio declined at roughly 17.4% per year (compound annual rate), from 105.93 to 18.86.
Where does this data come from?
Figures are computed from Inspire Medical Systems, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.